1048-P: Fasting C-Peptide as a Predictor for Hypoglycemia Risk and HbA1c Reduction in Chinese T2DM Patients Switching from Premixed to Basal Insulin: A Post Hoc Analysis from the Optimization Study

Objective: To explore the predictive effect of baseline fasting C-peptide (FCP) on hypoglycemia risk, HbA1c reduction, and treatment satisfaction in Chinese T2DM individuals switching from premixed to basal insulin. Methods: Post-hoc analysis of the single-arm, 16 weeks, phase IV OPTIMIZATION study....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2020-06, Vol.69 (Supplement_1)
Hauptverfasser:	YANG, WENYING, RUAN, PENGFEI, ZHANG, XIA, CUI, NAN
Format:	Artikel
Sprache:	eng
Schlagworte:	Diabetes Fasting Glucose Hemoglobin Hypoglycemia Insulin Patients Peptides
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!